Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Biological response and cytotoxicity induced by lipid nanocapsules.

Tytuł:
Biological response and cytotoxicity induced by lipid nanocapsules.
Autorzy:
Szwed M; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
Torgersen ML; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
Kumari RV; Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India.
Yadava SK; Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India.
Pust S; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
Iversen TG; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
Skotland T; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway.
Giri J; Department of Biomedical Engineering, Indian Institute of Technology, Hyderabad, India. .
Sandvig K; Department of Molecular Cell Biology, Institute for Cancer Research, Oslo University Hospital-The Norwegian Radium Hospital, Oslo, Norway. .; Department of Biosciences, University of Oslo, Oslo, Norway. .
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2020 Jan 06; Vol. 18 (1), pp. 5. Date of Electronic Publication: 2020 Jan 06.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: London : BioMed Central, 2003-
MeSH Terms:
Lipids/*toxicity
Nanocapsules/*toxicity
Activating Transcription Factor 4/metabolism ; Cell Death/drug effects ; Cell Line, Tumor ; Endocytosis/drug effects ; Ferroptosis/drug effects ; Homeostasis/drug effects ; Humans ; Hydrogen-Ion Concentration ; Lysosomes/drug effects ; Lysosomes/metabolism ; NF-E2-Related Factor 2/metabolism ; Nanocapsules/ultrastructure ; Oxidation-Reduction ; Protein Biosynthesis/drug effects ; Reactive Oxygen Species/metabolism ; Stress, Physiological/drug effects
References:
Nanomedicine. 2016 Jan;12(1):143-61. (PMID: 26410277)
Nat Rev Mol Cell Biol. 2011 Jul 22;12(8):517-33. (PMID: 21779028)
Nat Rev Mol Cell Biol. 2012 Jan 18;13(2):89-102. (PMID: 22251901)
J Cell Biol. 1987 Aug;105(2):679-89. (PMID: 2887575)
J Control Release. 2019 Jan 10;293:183-192. (PMID: 30529259)
Cancer Res. 1986 Dec;46(12 Pt 1):6387-92. (PMID: 2946403)
Life Sci. 2017 Oct 1;186:33-42. (PMID: 28782531)
ACS Cent Sci. 2017 Mar 22;3(3):232-243. (PMID: 28386601)
J Clin Biochem Nutr. 2019 Jan;64(1):1-12. (PMID: 30705506)
J Gen Physiol. 2011 Apr;137(4):385-90. (PMID: 21402887)
J Drug Target. 1996;3(5):391-8. (PMID: 8866658)
Int J Pharm. 2011 Jun 15;411(1-2):136-41. (PMID: 21463666)
Pharm Res. 2002 Jun;19(6):875-80. (PMID: 12134960)
Nanomedicine. 2015 Jul;11(5):1237-45. (PMID: 25791812)
Mol Biol Cell. 2018 Jan 1;29(1):53-65. (PMID: 29093026)
Toxicol In Vitro. 2017 Jun;41:189-199. (PMID: 28323104)
EMBO Rep. 2016 Oct;17(10):1374-1395. (PMID: 27629041)
Nanomedicine (Lond). 2014 Jul;9(9):1295-9. (PMID: 25204821)
Nat Rev Cancer. 2017 Jan;17(1):20-37. (PMID: 27834398)
Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-80. (PMID: 20402623)
J Cell Sci. 2017 Mar 1;130(5):927-937. (PMID: 28096475)
Mol Cell Biol. 2001 Dec;21(23):7971-80. (PMID: 11689689)
Nanotoxicology. 2019 Aug;13(6):761-782. (PMID: 30760074)
J Biol Chem. 1978 Nov 10;253(21):7798-803. (PMID: 701288)
J Control Release. 2013 Sep 28;170(3):334-42. (PMID: 23792117)
Trends Cell Biol. 2016 Mar;26(3):165-176. (PMID: 26653790)
Traffic. 2017 Mar;18(3):176-191. (PMID: 28067430)
Nat Rev Drug Discov. 2014 Nov;13(11):813-27. (PMID: 25287120)
Cell Rep. 2017 Dec 26;21(13):3662-3671. (PMID: 29281816)
Biomaterials. 2010 Oct;31(29):7542-54. (PMID: 20630585)
J Control Release. 2012 Jun 10;160(2):117-34. (PMID: 22484195)
Breast Cancer Res. 2011 Aug 12;13(4):215. (PMID: 21884641)
J Control Release. 2017 Nov 28;266:140-155. (PMID: 28951319)
Curr Opin Cell Biol. 2016 Apr;39:8-14. (PMID: 26827287)
J Biol Chem. 1983 Aug 25;258(16):9681-9. (PMID: 6309781)
Bio Protoc. 2017 Oct 5;7(19):null. (PMID: 29082291)
Redox Biol. 2017 Aug;12:191-197. (PMID: 28254657)
Int J Pharm. 2009 Sep 11;379(2):201-9. (PMID: 19409468)
Int J Mol Sci. 2017 Nov 18;18(11):null. (PMID: 29156588)
Biotechnol J. 2012 Jun;7(6):762-7. (PMID: 22581727)
Sci Rep. 2015 Mar 11;5:9004. (PMID: 25758662)
Grant Information:
228200 The Research Council of Norway; DST/IMRCD/INNO-INDIGO/NANOBREASTCO/2015 India Nanomission
Contributed Indexing:
Keywords: Breast cancer cells; Ferroptosis; Lipid nanocapsules; Stress responses
Substance Nomenclature:
0 (ATF4 protein, human)
0 (Lipids)
0 (NF-E2-Related Factor 2)
0 (NFE2L2 protein, human)
0 (Nanocapsules)
0 (Reactive Oxygen Species)
145891-90-3 (Activating Transcription Factor 4)
Entry Date(s):
Date Created: 20200108 Date Completed: 20201009 Latest Revision: 20201009
Update Code:
20240105
PubMed Central ID:
PMC6943936
DOI:
10.1186/s12951-019-0567-y
PMID:
31907052
Czasopismo naukowe
Background: Lipid nanocapsules (LNCs) are promising vehicles for drug delivery. However, since not much was known about cellular toxicity of these nanoparticles in themselves, we have here investigated the mechanisms involved in LNC-induced intoxication of the three breast cancer cell lines MCF-7, MDA-MD-231 and MDA-MB-468. The LNCs used were made of Labrafac™ Lipophile WL1349, Lipoid ® S75 and Solutol ® HS15.
Results: High resolution SIM microscopy showed that the DiD-labeled LNCs ended up in lysosomes close to the membrane. Empty LNCs, i.e. without encapsulated drug, induced not only increased lysosomal pH, but also acidification of the cytosol and a rapid inhibition of protein synthesis. The cytotoxicity of the LNCs were measured for up to 72 h of incubation using the MTT assay and ATP measurements in all three cell lines, and revealed that MDA-MB-468 was the most sensitive cell line and MCF-7 the least sensitive cell line to these LNCs. The LNCs induced generation of reactive free oxygen species and lipid peroxidation. Experiments with knock-down of kinases in the near-haploid cell line HAP1 indicated that the kinase HRI is essential for the observed phosphorylation of eIF2α. Nrf2 and ATF4 seem to play a protective role against the LNCs in MDA-MB-231 cells, as knock-down of these factors sensitizes the cells to the LNCs. This is in contrast to MCF-7 cells where the knock-down of these factors had a minor effect on the toxicity of the LNCs. Inhibitors of ferroptosis provided a large protection against LNC toxicity in MDA-MB-231 cells, but not in MCF-7 cells.
Conclusions: High doses of LNCs showed a different degree of toxicity on the three cell lines studied, i.e. MCF-7, MDA-MD-231 and MDA-MB-468 and affected signaling factors and the cell fate differently in these cell lines.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies